Article Details
Retrieved on: 2025-01-02 23:09:02
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growing biologics market driven by chronic diseases like diabetes, emphasizing biotechnology products and biosimilars for affordable treatments. Key players like AstraZeneca, Merck, and Eli Lilly are involved in innovations approved by the Food and Drug Administration.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here